U
MBOT icon

UBS’s Microbot Medical MBOT Stock Holding History

UBS’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$9K Sell
4
-3
-43% -$7.91K ﹤0.01% 8929
2014
Q2 		$22K Buy
7
+1
+17% +$2.31K ﹤0.01% 7952
2014
Q1 		$13K Hold
6
– – ﹤0.01% 8603
2013
Q4 		$12K Sell
6
-4
-40% -$8.47K ﹤0.01% 8781
2013
Q3 		$27K Buy
10
+6
+150% +$16.3K ﹤0.01% 7673
2013
Q2 		$10K Buy
+4
New +$11.3K ﹤0.01% 8629

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's MBOT Position: Q3 2014 in Review

UBS reduced its Microbot Medical (MBOT) stake by 43% in Q3 2014, selling an estimated $7.91K and leaving 4 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #8929.

UBS first reported a position in MBOT in Q2 2013 and has held it in 6 quarters since. The position peaked at $27K in Q3 2013. 39 funds tracked by Wall St. Rank hold MBOT as of Q3 2014.

  • UBS held 4 shares of Microbot Medical worth $9K as of Q3 2014.
  • UBS sold 3 Microbot Medical shares in Q3 2014, an estimated $7.91K.
  • Microbot Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8929 holding.
  • UBS first reported a position in Microbot Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Microbot Medical position peaked at $27K in Q3 2013.
  • 39 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.